The molecule is an investigational pre-clinical oral GLP-1 receptor agonist.
Merck Obtains Global License for Hansoh’s HS-10535
You May Also Like
Global Launch Strategies in the Current Political Climate
February 19, 2025
FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk
February 19, 2025
Navigating Distrust: Pharma in the Age of Social Media
February 18, 2025
+ There are no comments
Add yours